Article ; Online: Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification.
Molecular medicine (Cambridge, Mass.)
2023 Volume 29, Issue 1, Page(s) 168
Abstract: Background: Shenqi Compound (SQC) has been used in clinic for several decades in the prevention ...
| Abstract | Background: Shenqi Compound (SQC) has been used in clinic for several decades in the prevention and treatment of diabetes and its complications. But this is merely a heritage of experience. The primary aim of this study is to scientifically validate the therapeutic effects of SQC on diabetic vascular calcification (DVC) in an animal model and, simultaneously, uncover its potential underlying mechanisms. Method: Spontaneous diabetic rat- Goto Kakizaki (GK) rats were selected for rat modeling. We meticulously designed three distinct groups: a control group, a model group, and an SQC treatment group to rigorously evaluate the influence of SQC. Utilizing a comprehensive approach that encompassed methods such as pathological staining, western blot analysis, qRT-PCR, and RNA sequencing, we thoroughly investigated the therapeutic advantages and the underlying mechanistic pathways associated with SQC in the treatment of DVC. Result: The findings from this investigation have unveiled the extraordinary efficacy of SQC treatment in significantly mitigating DVC. The underlying mechanisms driving this effect encompass multifaceted facets, including the restoration of aberrant glucose and lipid metabolism, the prevention of phenotypic transformation of vascular smooth muscle cells (VSMCs) into osteogenic-like states, the subsequent inhibition of cell apoptosis, the modulation of inflammation responses, the remodeling of the extracellular matrix (ECM), and the activation of the Hippo-YAP signaling pathway. Collectively, these mechanisms lead to the dissolution of deposited calcium salts, ultimately achieving the desired inhibition of DVC. Conclusion: Our study has provided compelling and robust evidence of the remarkable efficacy of SQC treatment in significantly reducing DVC. This reduction is attributed to a multifaceted interplay of mechanisms, each playing a crucial role in the observed therapeutic effects. Notably, our findings illuminate prospective directions for further research and potential clinical applications in the field of cardiovascular health. |
|---|---|
| MeSH term(s) | Rats ; Animals ; Prospective Studies ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Diabetes Mellitus, Type 2/metabolism ; Vascular Calcification/drug therapy ; Vascular Calcification/complications ; Vascular Calcification/metabolism ; Myocytes, Smooth Muscle/metabolism |
| Chemical Substances | shenqi ; Drugs, Chinese Herbal |
| Language | English |
| Publishing date | 2023-12-13 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 1283676-x |
| ISSN | 1528-3658 ; 1076-1551 |
| ISSN (online) | 1528-3658 |
| ISSN | 1076-1551 |
| DOI | 10.1186/s10020-023-00767-7 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 4456: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.